3862 results for «453»
3862 results
Open design, confident delivery - How a novel LAA closure device provides predictable outcomes in complex anatomical settings
16 Nov 2025 – From PCR London Valves 2025
This session highlights a novel left atrial appendage (LAA) closure device featuring an open-cage design that delivers predictable clinical and procedural outcomes. It discusses the device's advantages in managing complex anatomical variations and presents implantation techniques across diverse anatomies to improve safety and efficacy.
Challenging tricuspid TEER
16 Nov 2025 – From PCR London Valves 2025
This session focuses on the intricacies of transcatheter tricuspid edge-to-edge repair (TEER) addressing iatrogenic tricuspid regurgitation, failed surgical valve repair, and approaches for patients unsuitable for valve replacement. It also examines the management of multiple clip detachments and the procedural nuances required to navigate complex tricuspid...
Planning a lifetime of care in younger patients with Evolut FX+: from index valve to future options
17 Nov 2025 – From PCR London Valves 2025
Watch this PCR London Valves 2025 session to take a deep look at the latest evidence in low-risk aortic stenosis, the durability of contemporary valves, and how anatomy — especially in women and patients with small annuli — shapes long-term strategy.
From index TAVI with Evolut FX+...
Complex combined interventions
16 Nov 2025 – From PCR London Valves 2025
This session presents complex combined interventions tackling multiple valvular and structural heart challenges simultaneously. It highlights innovative procedural approaches such as the 'super combo' techniques, strategies for managing deteriorative mitral regurgitation post-tricuspid valve replacement, and comprehensive management of torrential tricuspid regurgitation within rheumatic multivalvular disease contexts,...
Shaping the treatment of mitral regurgitation with the Intrepid transcatheter mitral valve replacement (TMVR) system
17 Nov 2025 – From PCR London Valves 2025
This session presents an in-depth examination of the Intrepid transcatheter mitral valve replacement (TMVR) system, focusing on its role in treating mitral regurgitation. It covers the system's design features, ongoing clinical research, and long-term durability, complemented by detailed analyses of transapical 5-year outcomes and current trial...
Single operator TAVI: where expertise meets consistency
18 Nov 2025 – From PCR London Valves 2025
This session addresses the concept of single operator transcatheter aortic valve implantation (TAVI), emphasizing the integration of expertise with procedural consistency. Follow a discussion on the benefits of simplifying TAVI to a single operator approach facilitated by an electronically enabled delivery system. The session offers a...
Hotline - Valvular and structural interventions
16 Nov 2025 – From PCR London Valves 2025
This session presents pivotal advances in valvular and structural heart interventions, covering the SMART-MV trial on mitral valvotomy safety, outcomes of TAVR patients with tricuspid regurgitation undergoing TEER, and the application of the FLOWer embolic protection system across structural heart procedures. Additionally, it explores the impact...
TAVI in 2025: transforming care with the new valvular heart disease guidelines
18 Nov 2025 – From PCR London Valves 2025
This session explores how the 2025 valvular heart disease guidelines are transforming the landscape of TAVI care and clinical decision-making. It highlights the paradigm shift in managing severe aortic stenosis and provides a global perspective on the challenges and strategies for managing an expanding TAVI patient...
The index valve matters: optimal index TAVI for a lifetime of possibilities
18 Nov 2025 – From PCR London Valves 2025
Discover how thoughtful index valve selection and implantation techniques can shape the long-term management of patients undergoing TAVI. This PCR London Valves 2025 session highlights treatment considerations for low- and intermediate-risk patients, explores how valve choice affects the feasibility of future interventions, and examines strategies to...
Mitral TEER - LIVE case
16 Nov 2025 – From PCR London Valves 2025
This live educational case from Hospital Álvaro Cunqueiro in Vigo, Spain, offers an in-depth look at Mitral TEER, including patient presentation, imaging analysis, operator strategy, and device overview. The session also features a recorded case from the Heart and Diabetes Center NRW in Germany, providing comprehensive...
The next frontier in LAA closure: innovations and opportunities
17 Nov 2025 – From PCR London Valves 2025
Explore the forefront of left atrial appendage (LAA) closure with this session focusing on the latest innovations and clinical opportunities. Topics include recent data on WATCHMAN FLX PRO and VersaCross Connect systems, workflow strategies to improve procedural efficiency, and discussions on upcoming clinical trials such as...
Valve selection in urgent TAVI: evidence from small annulus studies - Hotline
16 Nov 2025 – From PCR London Valves 2025
This session presents cutting-edge research comparing self-expanding and balloon-expandable valves in urgent and emergent TAVI settings, with a focus on small aortic annuli. It includes data from the NAVULTRA and LANDMARK trials, featuring novel biomimetic balloon-expandable valves and early feasibility studies that shed light on valve...
Hotline - Mitral and tricuspid valvular interventions
16 Nov 2025 – From PCR London Valves 2025
This session delves into innovative mitral and tricuspid valvular interventions, highlighting outcomes with the PASCAL precision system and advances in combined MitraClip and TriClip repairs. It discusses predictors of heart failure hospitalization post-transcatheter tricuspid valve repair (TTVR), coronary CT-based pacemaker implantation prediction, and novel devices aimed...
Shaping the future: top innovations at PCR London Valves 2025
16 Nov 2025 – From PCR London Valves 2025
Highlighting transformative innovations from PCR London Valves 2025, this session features advanced technologies such as the Luna TMVR with its unique intuitive design, the novel Tripair technology for tricuspid therapy, and insights into right heart remodeling following transcatheter tricuspid valve interventions with the DUO system, showcasing...
Featured research: clinical outcomes and real-world evidence in modern TAVI practice
16 Nov 2025 – From PCR London Valves 2025
This session presents featured research on Transcatheter Aortic Valve Implantation (TAVI), analyzing clinical impacts of prosthesis oversizing, same-day discharge experiences, and comparative outcomes of intra-annular versus supra-annular self-expanding valves. It also reviews nationwide TAVR data from Germany and meta-analyses assessing TAVI performance in centers without on-site...
PCR London Valves 2025 Welcome Ceremony
16 Nov 2025 – From PCR London Valves 2025
The PCR London Valves 2025 Welcome Ceremony marks the commencement of the conference, setting the stage for an immersive exploration of the latest advances and innovations in valvular heart disease management with a focus on transcatheter interventions.
New approaches in aortic regurgitation
16 Nov 2025 – From PCR London Valves 2025
Explore new diagnostic and therapeutic approaches for managing aortic regurgitation. This session covers imaging modalities, guideline-directed patient selection, current transcatheter treatment techniques, and emerging TAVI technologies designed specifically for non-calcific aortic valve pathology.
Procedural imaging for tricuspid valve interventions
16 Nov 2025 – From PCR London Valves 2025
Master procedural imaging techniques essential for tricuspid valve interventions, including TOE views, multi-phase reconstruction, and 3D/4D steering. This session also covers quantification of residual tricuspid regurgitation post-device deployment and the appropriate use of intracardiac echocardiography.
Redo TAVI - LIVE case
16 Nov 2025 – From PCR London Valves 2025
This session presents an educational case on redo transcatheter aortic valve implantation (TAVI) from Hospital Álvaro Cunqueiro, Spain, featuring patient presentation, imaging analysis, operator strategy, and procedural nuances, complemented by a recorded case from Poland.
LIVE Educational Case from Hospital Álvaro Cunqueiro - Vigo, Spain
The Silk Road of MedTech
16 Nov 2025 – From PCR London Valves 2025
Discover pioneering MedTech innovations along the Silk Road, including novel sheath designs for minimalist TAVR, self-expanding valves for pure aortic regurgitation, automated CT quantification via deep learning, and first-in-man experiences with cutting-edge valvuloplasty and TEER devices.
